LTR Pharma Limited (ASX:LTP)
Australia flag Australia · Delayed Price · Currency is AUD
0.4250
+0.0638 (17.66%)
Last updated: Jul 22, 2025

LTR Pharma Company Description

LTR Pharma Limited, a biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.

Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED.

The company was incorporated in 2020 and is headquartered in Brisbane, Australia.

LTR Pharma Limited
CountryAustralia
Founded2020
IndustryBiotechnology
SectorHealthcare

Contact Details

Address:
29/97 Creek Street
Brisbane, 4000
Australia
Phone61 18 0051 9711
Websiteltrpharma.com

Stock Details

Ticker SymbolLTP
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000305294
SIC Code2834

Key Executives

NamePosition
Lee RodneExecutive Chairman
Jacques SchipperChief Financial Officer
Peter McLennanChief Operating Officer
Prof. Geoffrey A. StrangeChief Medical Officer
Danny ZanardoChief Commercial Officer
David HwangJoint Company Secretary
Elizabeth SpoonerJoint Company Secretary